Home > National Drug Code (NDC) > bisoprolol fumarate and hydrochlorothiazide

bisoprolol fumarate and hydrochlorothiazide - 29300-187-13 - (bisoprolol fumarate and hydrochlorothiazide)

Alphabetical Index


Drug Information of bisoprolol fumarate and hydrochlorothiazide

Product NDC: 29300-187
Proprietary Name: bisoprolol fumarate and hydrochlorothiazide
Non Proprietary Name: bisoprolol fumarate and hydrochlorothiazide
Active Ingredient(s): 2.5; 6.25    mg/1; mg/1 & nbsp;   bisoprolol fumarate and hydrochlorothiazide
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of bisoprolol fumarate and hydrochlorothiazide

Product NDC: 29300-187
Labeler Name: Unichem Pharmaceuticals (USA), Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA079106
Marketing Category: ANDA
Start Marketing Date: 20101012

Package Information of bisoprolol fumarate and hydrochlorothiazide

Package NDC: 29300-187-13
Package Description: 30 TABLET in 1 BOTTLE, PLASTIC (29300-187-13)

NDC Information of bisoprolol fumarate and hydrochlorothiazide

NDC Code 29300-187-13
Proprietary Name bisoprolol fumarate and hydrochlorothiazide
Package Description 30 TABLET in 1 BOTTLE, PLASTIC (29300-187-13)
Product NDC 29300-187
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name bisoprolol fumarate and hydrochlorothiazide
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20101012
Marketing Category Name ANDA
Labeler Name Unichem Pharmaceuticals (USA), Inc.
Substance Name BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
Strength Number 2.5; 6.25
Strength Unit mg/1; mg/1
Pharmaceutical Classes Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]

Complete Information of bisoprolol fumarate and hydrochlorothiazide


General Information